Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis and DNA sequencing in Mycobacterium tuberculosis clinical isolates

New Microbiologica

Volumn 26, Issue 4, 2003, Pages 345-351

  Scarpellini, P ^a   Carrera, P ^a   Cichero, P ^a   Gelfi, C ^b   Gori, A ^b   Ferrari, M ^a   Zingale, A ^a   Lazzarin, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Denaturing gradient gel electrophoresis; inhA; Isoniazid resistance; KatG; Mycobacterium tuberculosis; oxyR ahpC

Indexed keywords

ISONIAZID; BACTERIAL DNA; BACTERIAL PROTEIN; CATALASE HPI; PEROXIDASE; TUBERCULOSTATIC AGENT;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; GENE; GENE MUTATION; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; DRUG EFFECT; ELECTROPHORESIS; GENETICS; HUMAN; METHODOLOGY; NUCLEOTIDE SEQUENCE; SENSITIVITY AND SPECIFICITY;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS; GENOTYPE; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PEROXIDASES; SENSITIVITY AND SPECIFICITY;

EID: 0642372733     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BOOM, R., SOL, C.J.A., SALIMAS, M.M.M., JANSEN, C.L., WERTHEIM-VAN DILLEN, P.M. E., and VAN DER NOORDAA, J. (1990). Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology, 28, 495-503.
2. CREMONESI, L., CARRERA, P., FUMAGALLI, A., LUCCHIARI, S., CARDILLO, E., FERRARI, M., RIGHETTI, S.C., ZUMINO, F., RIGHETTI, P.G., and GELFI, C. (1999). Validation of double gradient denaturing gradient gel electrophoresis through multigenic retrospective analysis. Clinical Chemistr, 45, 35-40.
3. CREMONESI, L., FIRPO, S., FERRARI, M., RIGHETTI, P. G., and GELFI, C. (1997). Double-gradient DGGE for optimization detection of DNA point mutations. BioTechniques., 22, 326-330.
4. FISCHER, S.G., and LERMAN, L. (1982). Analysis of point mutations by denaturing gradient gel electrophoresis. Proceedings of the National Academy of Sciences of the United States of America, 80, 1579-1583.
5. HEYM, B., ALZAVI, P.M., HONORE, N., and COLE, S.T. (1995). Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Molecular Microbiology, 15, 235-245.
6. HEYM, B., HONORE, N., TRUFFOT-PERNOT, C., BANERJEE, A., SCHURRA, C., JACOBS JR., W.R., VAN EMBDEN, J.D., GROSSET, J.H., and COLE, S.T. (1994). Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet, 344, 293-298.
7. KAPUR, V., LING-LING, L., HAMRICK, M.R., PLIKAYTIS, B.B., SINNICK, T.M., TELENTI, A., JACOBS JR., W.R., BANERJEE, A., COLE, S.T., YUEN, K.Y., CLARIDGE III, I.E., KREISWIRTH, B., and MUSSER, J.M. (1995). Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Archives of Pathology and Laboratory Medicine, 119, 131-138.
8. KELLEY, C.L., ROUSE, D.A., and MORRIS, S.L. (1997). Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 41, 2057-2058.
9. KIEPIELA, P., BISHOP, K.S., SMITH, A.N., ROUX, L., and YORK, D.F. (2000). Genomic mutations in the katG, inhA and ahpC are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tubercle and Lung Disease, 1, 47-56.
10. LEE, A.S.G., LIM, I.H.K., TANG, L.L.H., TELENTI, A., and WONG, S.Y. (1999). Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrobial Agents and Chemotherapy, 43, 2887-2889.
11. LEI, B., WEI, C.-J., and Tu, S.-C. (2000). Action mechanism of antitubercular isoniazid. The Journal of Biological Chemistry, 275, 2520-2526.
12. MARTTILA, H.J., SOINI, H., HUOVINEN, H.P., and VILJANEN, M.K. (1996). KatG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrobial Agents and Chemotherapy, 40, 2187-2189.
13. MDLULI, K., SLAYDEN, R.A., ZHU, Y.Q., RAMASWAMY, S., PAN, X., MEAD, D., CRANE, D.D., MUSSER, J.M., and BARRY III, C.E. (1998). Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science, 280, 1607-1610.
14. MUSSER, J.M., KAPUR, V., WILLIAMS, D.L., KREISWIRTH, B.N., VAN SOOLINGEN, D., and VAN EMBDEN, J.D.A. (1996) Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. Juornal of Infectious Diseases, 173, 196-202.
15. NACHMAKIN, E., KANG, C., and WEINSTEIN, M.P. (1997). Detection of resistance to isoniazid, rifampin and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Cliical and Infectious Diseases, 24, 894-900.
16. PIATEK, A.S., TELENTI, A., MURRAY, M.R., EL-HAJJ, H., JACOBS, W.R.J., KRAMER, F.R., and ALLAND, D. (2000). Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrobial Agents and Chemotherapy, 44, 103-110.
17. ROUSE, D.A., DEVITO, J.A., LI, Z., BYER, M., and MORRIS, S.L. (1996). Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis effects on catalase-peroxidase activities and isoniazid resistance. Molecular Microbiology, 22, 583-592.
18. ROUSE, D.A., LI, Z., BAI, G.H., and MORRIS, S.L. (1995). Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 39, 2472-2477.
19. SCARPELLINI, P., BRAGLIA, S., CARRERA, P., CEDRI, M., CICHERO, P., COLOMBO, A., CRUCIANELLI, R., GORI, A., FERRARI, M., and LAZZARIN, A. (1999). Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrobial Agents and Chemotherapy, 43, 2550-2554.
20. SREVASTAN, S., PAN, X., ZHANG, Y., DERETIC, V., and MUSSER, J.M. (1997). Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrobial Agents and Chemotherapy, 41, 600-606.
21. TELENTI, A., HONORÉ, H., BERNASCONI, C., MARCH, J., ORTEGA, A., HEYM, B., TAKIFF, H.E., and COLE, S.T. (1997). Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. Journal of Clinical Microbiology, 35, 719-723.
22. VAN EMBDEN, J.D.A., CAVE, M.D., CRAWFORD, J.T., DALE, J.W., EISENACH, K.D., GIQUEL, B., HERMANS, P., MARTIN, C., MCADAM, R., SINNICK, T.M., and SMALL, P.M. (1993). Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. Journal of Clinical Microbiology, 31, 406-409.
23. WEI, C.-J., LEI, B., MUSSER, J.M., and TU, S.-C. (2003). Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrobial Agents and Chemotherapy, 47, 670-675.